Article

[Alzheimer's disease and human memory].

Inserm-EPHE-Université de Caen/Basse-Normandie, Unité E0218, GIP Cyceron, CHU Côte de nacre, Caen, France.
Revue Neurologique (Impact Factor: 0.6). 11/2006; 162(10):929-39.
Source: PubMed

ABSTRACT Memory disorders observed in Alzheimer's disease gave rise, from the eighties, to a detailed analysis into the framework of cognitive neuropsychology which aimed at describing the deficits of very specific processes. Beyond their clinical interest, these studies contributed to the modelisation of human memory thanks to the characterization of different memory systems and their relationships. The first part of this paper gives an overview of the memory deficits in Alzheimer's disease and insists on particular cognitive phenomena. Hence, several examples are developed in the domains of semantic memory (such as hyperpriming and hypopriming effects) and autobiographical memory. Recent results highlight the existence of severe autobiographical amnesia observed in all neurodegenerative diseases, though with contrasting profiles: Ribot's gradient in Alzheimer's disease (showing that remote memories are better preserved than recent ones), reverse gradient in semantic dementia and no clear gradient in the frontal variant of frontotemporal dementia. The second part of this article presents advances in cognitive neuroscience searching to disclose the cerebral substrates of these cognitive deficits in Alzheimer's disease. The studies using functional imaging techniques are the most informative regarding this problematic. While showing the dysfunctions of an extended network, they emphasize the selectivity of cerebral damages that are at the root of very specific cognitive dysfunctions, coming close in that way to the conceptions of cognitive neuropsychology. These neuroimaging studies unravel the existence of compensatory mechanisms, which until recently were clearly missing in the literature on neurodegenerative diseases. These different researches lead to a wide conception of human memory, not just limited to simple instrumental processes (encoding, storage, retrieval), but necessarily covering models of identity and continuity of the subject, which interact in a dynamic way with eminently changing memory representations.

2 Followers
 · 
146 Views
  • Source
    • "Alzheimer's disease (AD) is a neurodegenerative disorder that frequently begins with memory complaints progressing to a severe deterioration of multiple memory systems (Eustache et al., 2006). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Intraneuronal accumulation of amyloid β (iAβ) has been linked to mild cognitive impairment that may precede Alzheimer's disease (AD) onset. This neuropathological trait was recently mimicked in a novel animal model of AD, the hemizygous transgenic McGill-R-Thy1-APP (Tg+/−) rat. The characterization of the behavioral phenotypes in this animal model could provide a baseline of efficacy for earlier therapeutic interventions. The aim of the present study was to undertake a longitudinal study of Aβ accumulation and a comprehensive behavioral evaluation of this transgenic rat model. We assessed exploratory activity, anxiety-related behaviors, recognition memory, working memory, spatial learning and reference memory at 3, 6, and 12 months of age. In parallel, we measured Aβ by ELISA, Western blots and semiquantitative immunohistochemistry in hippocampal samples. SDS-soluble Aβ peptide accumulated at low levels (~9 pg/mg) without differences among ages. However, Western blots showed SDS-resistant Aβ oligomers (~30 kDa) at 6 and 12 months, but not at 3 months. When compared to wild-type (WT), male Tg+/− rats exhibited a spatial reference memory deficit in the Morris Water Maze (MWM) as early as 3 months of age, which persisted at 6 and 12 months. In addition, Tg+/− rats displayed a working memory impairment in the Y-maze and higher anxiety levels in the Open Field (OF) at 6 and 12 months of age, but not at 3 months. Exploratory activity in the OF was similar to that of WT at all-time points. Spatial learning in the MWM and the recognition memory, as assessed by the Novel Object Recognition Test, were unimpaired at any time point. The data from the present study demonstrate that the hemizygous transgenic McGill-R-Thy1-APP rat has a wide array of behavioral and cognitive impairments from young adulthood to middle-age. The low Aβ burden and early emotional and cognitive deficits in this transgenic rat model supports its potential use for drug discovery purposes in early AD.
    Frontiers in Behavioral Neuroscience 09/2014; 8(321). DOI:10.3389/fnbeh.2014.00321 · 4.16 Impact Factor
  • Source
    • "In keeping with the overall phenomenon of population ageing, an increase in age-related neurodegenerative disorders (namely Alzheimer's Disease [AD]) has been observed, characterized by memory impairment and cognitive dysfunction (Ferri et al., 2005). Moreover, during normal and pathological ageing, episodic and working memories as well as attentional processes are affected from early stages on (Eustache et al., 2006). Such cognitive disorders seem to be mainly due to the impairment of neuronal ability to synthesize and release certain neurotransmitters (Bartus et al., 1982; Westphalen et al., 2003; Francis, 2005). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Imbalance between GABAergic and glutamatergic neurotransmission has been recently hypothesized to trigger memory decline related either to ageing or to Alzheimer's disease (AD). Thereby, benzodiazepine-induced anterograde amnesia has been construed as a model of hippocampal-related cognitive dysfunctions. Since spatial memory is altered both by ageing and by benzodiazepines such as alprazolam, we investigated the pharmacological sensitivity of alprazolam-induced deficit in a delayed spatial discrimination (SD) task, notably with positive allosteric modulators of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)-type glutamate receptors. We showed that alprazolam (0.1 mg/kg intraperitoneally) induced memory impairments as compared with vehicle-treated mice. The oral administration of modulators of AMPA receptors (IDRA-21: 10 mg/kg; S18986: 3 and 10 mg/kg) reversed the alprazolam-induced deficits. This study is first to show evidence that reference treatments of AD, such as memantine (a NMDA receptor antagonist) at 3 mg/kg per os (po) and donepezil (an acetylcholinesterase inhibitor) at 1 mg/kg po, also reversed the alprazolam-induced amnesia. Given such results, the SD task emerges as a valuable novel task to screen pro-cognitive compounds. Thus, we highlight the efficacy of modulators of AMPA-type glutamate receptors to counteract alprazolam-induced spatial deficits. These results could be viewed alongside the imbalance between excitation and inhibition observed during normal and pathological ageing.
    Journal of Psychopharmacology 09/2011; 26(6):845-56. DOI:10.1177/0269881111416692 · 2.81 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Pour certaines problématiques biomédicales, notamment en neurobiologie, l'imagerie des échantillons exige des résolutions spatiale et temporelle élevées, et seules des techniques de microscopie optique innovantes vont permettre d'imager la cellule dans des conditions physiologiques. Pour répondre à ces contraintes nous avons développé en intégralité un dispositif de microscopie de fluorescence en réflexion totale interne et résolue en temps. En effet, l'imagerie de fluorescence résolue en temps (FLIM) permet, en complément des informations de localisation et de topologie apportées par la microscopie conventionnelle, une analyse dynamique de processus moléculaires et métaboliques au sein des cellules. Associée à la technique de microscopie en réflexion totale interne, qui confère au système d'imagerie une résolution axiale sub-longueur d'onde tout en acquérant des images en champ large, la technique FLIM permet d'analyser l'activité membranaire des cellules en s'affranchissant de la fluorescence des autres entités de la cellule. Ce travail s'est articulé autour de trois axes principaux : l'étude et le développement d'un dispositif d'excitation de la fluorescence basé sur un oscillateur laser solide picoseconde dont le spectre est élargi par effets non linéaires dans des fibres optiques microstructurées ; le développement et la caractérisation d'un dispositif de microscopie de fluorescence par onde évanescente (TIRF) couplé à une détection résolue en temps en plein champ ; et l'application de ce dispositif à l'étude d'un précurseur membranaire du peptide amyloïde impliqué dans la maladie d'Alzheimer.
Show more